Clinical Trial Update: Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing high-dose PPOIT and high-dose peanut OIT to low-dose peanut OIT for peanut allergy has been withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• PPOIT (Probiotic Peanut Oral Immunotherapy)
• Peanut Oral Immunotherapy (OIT) High Dose (Peanut Oral Immunotherapy)
• Peanut Oral Immunotherapy (OIT) Low Dose (Peanut Oral Immunotherapy)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Peanut Allergy | Phase 2 | Status: WITHDRAWN